This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Short guide to identifying dividend ETFs with the absolute lowest fees and what to consider beyond price.
27,457 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Nebius Group flags a fragile link between borrowing costs and AI investment. The remarks underscore how rate moves fr...
Equity Union Real Estate leverages an agent-first model to propel 2025 loan production, earning recognition as a 2026...
XRP sees a rapid surge in on-chain wallet creation and rising derivatives activity, signaling potential shifts in tra...
Investors eye SpaceX's potential IPO as the space economy broadens; public peers already provide exposure across laun...
Drew Barrymore’s 280-year-old Westchester weekend retreat has secured a buyer, after listing for $4.99 million. The d...
A news-driven swing in Ondas stock sparked investor curiosity. This guide breaks down the catalysts, what it means fo...
Peter Thiel's AI warning collides with rising demand for storytellers, prompting a reassessment of career paths and p...
Nebius stock has drawn attention for rapid AI cloud growth, but two core risks could derail momentum. This guide give...
Cardano’s ADA dropped sharply, slipping below $0.20 as risk-off sentiment gripped crypto markets. A high-profile upda...
A landmark $1.5 billion bet on counter-drone tech sets Motorola Solutions up for deeper public-safety leadership. Her...
A new AP-NORC poll shows growing doubt about the American Dream as the nation approaches its 250th birthday, with you...